FDA seeks to pull OTC nasal decongestant ingredient due to lack of efficacy

After 17 years of back and forth with citizen petitions and two advisory committees, the FDA on Thursday proposed to pull commonly-used nasal decongestant active ingredients in common over-the-counter drugs like Sudafed found to be ...